Hansoh Pharmaceutical's commendable ROE, impressive earnings...
Hansoh Pharmaceutical's commendable ROE, impressive earnings growth, and profit reinvestment strategy signal positive performance. Future payout ratio is pegged around 22% and ROE about 12%. Analysts foresee gain in the company's earnings.
Is Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Recent Stock Performance Tethered To Its Strong Fundamentals?
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment